DVA
Stock Details
DVA is DaVita Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 80.76$. Average daily volumn in 3 months 670.56k. Market cap 7.18B
Stock symbol : DVA. Exchange : NYSE. Currency : USD Lastest price : 78.19$. Total volume : 176.92k. Market state REGULAR Click reload if you want to check the lastest price on market!!!
DaVita Inc. (DVA)
Last Price
78.19$Change
1.42Volume
176.92k
| Previous Close | 76.77 |
| Open | 77.11 |
| Day Range | 77.11-79.32 |
| Bid | 78.54 x 800 |
| Ask | 78.59 x 1.4k |
| Volume | 176.92k |
| Average Volume | 670.56k |
| Market Cap | 7.18B |
| Beta | 0.95 |
| 52 Week Range | 65.28-124.81 |
| Trailing P/E | 13.91 |
| Foward P/E | 11.08 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | N/A |
Financial Details
Organization
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative se... rvices to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Market Cap:
7.18BRevenue:
11.61BTotal Assets:
16.93BTotal Cash:
244.09M
News about "DaVita Inc."
DaVita Inc. stock rises Tuesday, outperforms market
Source from : MarketWatch - 6 days ago
Shares of DaVita Inc. advanced 2.05% to $76.60 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P ...See details»
DaVita Inc. to Participate in the Barclays 2023 Global Healthcare Conference
Source from : Yahoo - 6 days ago
DENVER, March 13, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Barclays ...See details»
DaVita (DVA) to Report Q4 Earnings: What's in the Offing?
Source from : Nasdaq - 28 days ago
DaVita Inc. DVA is scheduled to release fourth-quarter 2022 results on Feb 22, after the closing bell. In the last reported quarter, the company’s earnings of $1.45 per share lagged the Zacks ...See details»
DaVita Inc. To Participate In The Barclays Global Healthcare Conference; Webcast At 3.05 PM ET
Source from : Nasdaq - 6 days ago
(RTTNews) - DaVita Inc. (DVA) will participate in a fireside chat with investors at the Barclays 2023 Global Healthcare Conference. The event is scheduled to begin at 3:05 PM ET on March 14 ...See details»
Client Profile: DaVita Inc
Source from : OpenSecrets.org - 1 month ago
DaVita Inc $5,250,000 Javier D Martinez Revolving Door Profiles Non Former Members of Congress DaVita Inc $5,250,000 Kelly Philson No Revolving Door Profiles Non Former Members of Congress DaVita Inc ...See details»
DaVita faces another probe over ties to kidney care charity
Source from : STAT - 24 days ago
The D.C. attorney general is investigating the dialysis provider DaVita and its ties to the nonprofit American Kidney Fund.See details»
DaVita Inc
Source from : OpenSecrets.org - 1 month ago
No identified affiliates for DaVita Inc in the 2020 election cycle. Contributions to 527s are not included in the Individuals, PACs, Soft (Indivs), or Soft (Orgs) columns, so the sum of these columns ...See details»
DaVita Inc. 4th Quarter 2022 Results
Source from : Yahoo - 26 days ago
DENVER, Feb. 22, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2022. "We continue to have excitement and ...See details»
DaVita falls as labor headwinds weigh on 2023 outlook
Source from : Seeking Alpha - 24 days ago
DaVita (NYSE:DVA) was a notable underperformer in the S&P 500 on Thursday as the dialysis services provider slightly missed Q4 revenue estimates and issued in-line guidance amid ongoing labor ...See details»
DaVita: Valuations, Forward Growth Unsupportive Of Buy
Source from : Seeking Alpha - 18 days ago
Mixed Q4 results throughout the P&L and per-patient measures. Projects flat bottom-line growth in FY23, with further downsides in FCF. Valuations aren't supportive of a re-rating or valuation ...See details»
Medtronic and DaVita’s dialysis venture appears to be called Mozarc Medical
Source from : MassDevice - 6 days ago
Clues are pointing to Mozarc Medical as the name of the new kidney care company that Medtronic and DaVita are expected to launch this year.See details»
DaVita (DVA) Earnings Dates & Reports
Source from : Investing - 26 days ago
View upcoming earnings forecasts and in-depth analysis of company forecasts.See details»
DaVita Inc. to Participate in the Barclays 2023 Global Healthcare Conference
Source from : Benzinga.com - 7 days ago
DENVER, March 13, 2023 /PRNewswire/ -- DaVita Inc. DVA today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Barclays 2023 Global ...See details»
DaVita Inc.
Source from : Wall Street Journal - 1 year ago
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...See details»